|
||
---|---|---|
UniProt ID |
P19022 |
|
Entry Name |
CADH2_HUMAN |
|
Protein Name |
Cadherin-2 |
|
Primary Gene Name |
CDH2 |
|
Organism |
Homo sapiens (Human) |
|
Molecular Function | ||
Membrane Location |
Cell membrane |
|
---|
Substrate Name | N-cadherin | |
Cell Type | mouse neuroblastoma N2a cells, human neuroglioma H4 cells | |
Substrate Description | cell migration; neurite outgrowth | |
Substrate Function Category | central nervous system (neuron);disease | |
Substrate Function Subtype | Central nervous system (CNS) pathology; cell adhesion molecules | |
Sheddase | ADAM10 | |
Shedding-related Disease | cell adhesion molecule; cancer (prostate) | |
Short Summary of Papers | release of the extracellular domain, for the regulation of cell adhesion, cell migration. decreased neuronal cell adhesion, increased neurite outgrowth | |
Cleavage Information | NONE | |
PMID | 19049889 15692570 18951988 16998833 |
|
---|
|
||
---|---|---|
|
Start | End |
|
160 | 724 |
|
725 | 745 |
|
||||||||
---|---|---|---|---|---|---|---|---|
Database | CutSeq | Mapped Position | Protease | Type | Evidence | PMID | ||
ASCENT | SVEA*SGEI | 25 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | AVKL*SLKP | 121 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | AVKL*SLKP | 121 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
MEROPS | RQKR*DWVI | 159 | kallikrein-related peptidase 4 | physiologically relevant | consensus sequence | 15389820    | ||
PAPER | RQKR*DWVI | 159 | UNKNOWN | Mass spectrometry | 33796845    | |||
PAPER | PSPN*MFTI | 319 | UNKNOWN | Mass spectrometry | 33796845    | |||
ASCENT | FTAM*TFYG | 385 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | FTAM*TFYG | 385 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | FTAM*TFYG | 385 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
ASCENT | TAMT*FYGE | 386 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | TAMT*FYGE | 386 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | TAMT*FYGE | 386 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
ASCENT | AMTF*YGEV | 387 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | MFVL*TVAA | 460 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | MFVL*TVAA | 460 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | MFVL*TVAA | 460 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
ASCENT | FVLT*VAAE | 461 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | VLTV*AAEN | 462 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | VLTV*AAEN | 462 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | LTVA*AENQ | 463 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | LTVA*AENQ | 463 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | VSVT*VIDV | 487 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | AGTM*LTTF | 515 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | GTML*TTFT | 516 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | TMLT*TFTA | 517 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
ASCENT | MLTT*FTAQ | 518 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | LTTF*TAQD | 519 | UNKNOWN | subtiligase-based N-terminal sequencing | ||||
ASCENT | QNIR*YTKL | 533 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | YTKL*SDPA | 537 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | AGPF*AFDL | 637 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
ASCENT | AGPF*AFDL | 637 | UNKNOWN | subtiligase-based N-terminal sequencing | 33536314    | |||
PAPER | No_information | ADAM10 | Gel electrophoresis | 15692570    | ||||
PMAP | No_information | matrix metallopeptidase | This entry is based on an experiment | 14960160    12775583    | ||||
PMAP | No_information | gingipain R1 | This entry is based on an experiment | Gel electrophoresis | 16988242    | |||
PMAP | No_information | gingipain K | This entry is based on an experiment | Gel electrophoresis | 16988242    |
|
|||
---|---|---|---|
Secretome Database | Cell Type or Body Fluid | PubMed Reference | |
PAPER | cancer(ovary) | 18560578 | |
Sys-BodyFluid | Amniotic fluid | 17495049 | |
Sys-BodyFluid | Cerebrospinal fluid | 17853512 | |
Sys-BodyFluid | Cerebrospinal fluid | 18052119 | |
Sys-BodyFluid | Cerebrospinal fluid | 15582749 | |
Sys-BodyFluid | Cerebrospinal fluid | 14998169 | |
Sys-BodyFluid | Urine | 16335936 | |
Sys-BodyFluid | Urine | 16281181 | |
Sys-BodyFluid | Urine | 16948836 | |
Sys-BodyFluid | Plasma/Serum | 16104056 | |
HCSD | cancer (gastric cancer) | 23161554 | |
HCSD | cancer (lung cancer) | 19776420 | |
HCSD | cancer(prostate cancer) | 22908226 | |
HCSD | cancer(23 cancer cell lines) | 20124221 | |
HCSD | cancer(colorectal cancer | 24418523 | |
HCSD | cancer(urothelial carcinoma) | 23591195 | |
HCSD | cancer(glioblastoma multiforme) | 21574646 | |
HCSD | cancer(breast cancer) | 24505115 | |
HCSD | cancer(non small cell lung cancer) | 19655816 |